Comprehensive Approach to Managing Co-infection of Multidrug-Resistant Tuberculosis, HIV, and Hepatitis B in Ghana: A Case Study
Clinical Scorecard: Comprehensive Approach to Managing Co-infection of Multidrug-Resistant Tuberculosis, HIV, and Hepatitis B in Ghana: A Case Study
At a Glance
Category Detail
Condition Key Mechanisms Overlapping drug toxicities and limited treatment options complicate management. Target Population Care Setting
Key Highlights
Patient diagnosed with rifampicin-resistant pulmonary TB and chronic hepatitis B. Challenges included drug stockouts and chronic renal impairment. Patient completed a 12-month MDR-TB regimen with microbiological cure. Ongoing antiretroviral therapy for HIV; hepatitis B and renal disease under monitoring. Guideline-Based Recommendations
Diagnosis
Routine screening for HBV among HIV-positive patients is recommended but not widely implemented. Management
Integrated management of MDR-TB, HIV, and hepatitis B is essential. Monitoring & Follow-up
Clinical monitoring of hepatitis B and renal disease is necessary. Risks
Increased risk of treatment failure and adverse drug reactions due to co-infection. Patient & Prescribing Data
HIV-positive individuals with co-infection of MDR-TB and hepatitis B.
Cost of managing chronic HBV infection is a barrier for many patients.
Clinical Best Practices
Ensure continuity of care despite drug stockouts. Implement multidisciplinary approaches to manage co-infections. Related Resources & Content
